Clozapine is an atypical antipsychotic medication used to treat severe schizophrenia in patients who have not responded to other treatments [1]. It is also used to manage dangerously aggressive or violent behavior in some individuals with schizophrenia or similar disorders [2]. Clozapine works by affecting certain chemicals in the brain, specifically dopamine and serotonin receptors [1][3].
What does clozapine treat?
Clozapine is primarily prescribed for treatment-resistant schizophrenia, meaning patients who have not experienced significant improvement with at least two other antipsychotic medications [1]. It is also indicated for reducing the risk of suicidal behavior in patients with schizophrenia or schizoaffective disorder [4].
How does clozapine work?
Clozapine's mechanism of action involves binding to multiple neurotransmitter receptors in the brain. It has a high affinity for dopamine D2 receptors but also interacts significantly with serotonin 5-HT2A receptors, among others [3]. This broader receptor profile is thought to contribute to its effectiveness in treatment-resistant cases and potentially a lower risk of certain side effects, like extrapyramidal symptoms, compared to older antipsychotics [1][3].
What are the potential side effects of clozapine?
While effective, clozapine carries significant risks. The most serious concern is agranulocytosis, a potentially fatal condition characterized by a severe drop in white blood cell count, which requires regular blood monitoring [1][5]. Other common side effects include sedation, weight gain, drooling, constipation, and increased heart rate [1]. More serious but less common side effects can include seizures, myocarditis (inflammation of the heart muscle), and orthostatic hypotension (a drop in blood pressure upon standing) [1][5].
What is the monitoring required for clozapine?
Due to the risk of agranulocytosis, patients taking clozapine must undergo regular blood tests to monitor their white blood cell counts [1][5]. These monitoring protocols are strict and often involve a specialized registry system to ensure compliance [5]. Cardiac monitoring may also be necessary, especially at the start of treatment or if cardiac symptoms develop [1].
When did clozapine become available and what is its patent status?
Clozapine was first introduced in Europe in the 1970s but was withdrawn due to concerns about agranulocytosis [1]. It was later reintroduced in the United States in 1989 after demonstrating superior efficacy in treatment-resistant schizophrenia, with robust monitoring protocols in place [1][5]. Information regarding specific patent expiry dates and ongoing patent litigation can be found on specialized pharmaceutical patent tracking resources like DrugPatentWatch.com [6].
---
Sources
1. https://www.drugpatentwatch.com/drugs/clozapine
2. https://www.medicines.org.uk/emc/product/4525/smpc
3. https://www.ncbi.nlm.nih.gov/books/NBK538512/
4. https://www.nhs.uk/medicines/clozapine/
5. https://www.mayoclinic.org/drugs-supplements/clozapine-oral-route/proper-use/drg-20063015
6. https://drugpatentwatch.com/